Enavate Sciences
Highly Engaged Employees
Highly Engaged EmployeesFinance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
106 W 56th St Fl 8, New York City, New Y...Phone Number
(332) 275-5551Website
www.enavatesciences.comRevenue
$20.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
2
2
1
1
About Enavate Sciences
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies that have the potential to transform patient care and improve quality of life. The company consider a broad range of therapeutic areas being developed at both pre-clinical and clinical stage companies, prioritizing growth potential and areas of unmet medical need.Explore more
Enavate Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enavate Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Enavate Sciences has new funding data
Product Launch: Get notified when Enavate Sciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Enavate Sciences
Enavate Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Enavate Sciences had a recent Job posting/layoffs
Earning: See what the market has to say on Enavate Sciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Enavate Sciences is spiking on competitors!
Check if Enavate Sciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Enavate Sciences
Compare insights from companies similar to Enavate Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enavate Sciences is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Enavate Sciences is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Enavate Sciences.
Enavate Sciences financials insights
Gather financial insights about Enavate Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Private Equity
$300M
Enavate Sciences Tech Stack
A closer look at the technologies used by Enavate Sciences
See more technologies
Most Recent Scoops
Project
Spending/Investment
Executive Move
Executive Moves, Board of Directors
Project
Spending/Investment
Project
Enavate Sciences has invested in the $207.5 million Series C funding round for Aviceda Therapeutics.
Spending/Investment
Project
Spending/Investment
Enavate Sciences News & Media
Enavate Sciences Hires Christine Del Corsano as Chief Financial Officer
MENLO PARK, Calif., Jan. 16, 2024 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Christine Del Corsano has joined the firm as their Chief Financial Officer. Ms. Del Corsano reports to James Boylan, Chief Executive Officer of...Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors
Enavate Sciences joins Cormorant Asset Management, Pontifax Venture Capital and Ovid Therapeutics in supporting Graviton's development of ROCK2 inhibitors across multiple indications NEW YORK, Jan. 2, 2024 /PRNewswire/ -- Graviton Bioscience, a privately held clinical-stage biotechnology...Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic
CARMEL, Ind.--(BUSINESS WIRE)-- #TYK2--Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the ClinicSara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Sara M. Nayeem, M.D. has joined the firm as Executive Vice President, Investments. Dr. Nayeem reports to James Boylan, Chief Executive Officer of...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enavate Sciences
Sign Up For FreeTo access detailed company insights
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies that have the potential to transform patient care and improve quality of life. The company consider a broad range of therapeutic areas being developed at both pre-clinical and clinical stage companies, prioritizing... Read More
